Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4,378 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
An epidemiological study on the course of disease and therapeutic considerations in relapsing-remitting multiple sclerosis patients receiving injectable first-line disease-modifying therapies in Germany (EPIDEM).
Schmidt S, Koehler J, Winterstein C, Schicklmaier P, Kallmann B. Schmidt S, et al. Ther Adv Neurol Disord. 2018 Jan 23;11:1756285617749802. doi: 10.1177/1756285617749802. eCollection 2018. Ther Adv Neurol Disord. 2018. PMID: 29399053 Free PMC article.
Incidence and mitigation of gastrointestinal events in patients with relapsing-remitting multiple sclerosis receiving delayed-release dimethyl fumarate: a German phase IV study (TOLERATE).
Gold R, Schlegel E, Elias-Hamp B, Albert C, Schmidt S, Tackenberg B, Xiao J, Schaak T, Salmen HC. Gold R, et al. Among authors: schmidt s. Ther Adv Neurol Disord. 2018 Apr 18;11:1756286418768775. doi: 10.1177/1756286418768775. eCollection 2018. Ther Adv Neurol Disord. 2018. PMID: 29707040 Free PMC article.
Endocarditis following ocrelizumab in relapsing-remitting MS.
Faissner S, Schwake C, Gotzmann M, Mügge A, Schmidt S, Gold R. Faissner S, et al. Among authors: schmidt s. Neurol Neuroimmunol Neuroinflamm. 2020 Feb 3;7(3):e680. doi: 10.1212/NXI.0000000000000680. Print 2020 May. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32014890 Free PMC article. No abstract available.
Electrocardiographic assessments and cardiac events after fingolimod first dose - a comprehensive monitoring study.
Limmroth V, Ziemssen T, Lang M, Richter S, Wagner B, Haas J, Schmidt S, Gerbershagen K, Lassek C, Klotz L, Hoffmann O, Albert C, Schuh K, Baier-Ebert M, Wendt G, Schieb H, Hoyer S, Dechend R, Haverkamp W. Limmroth V, et al. Among authors: schmidt s. BMC Neurol. 2017 Jan 18;17(1):11. doi: 10.1186/s12883-016-0789-7. BMC Neurol. 2017. PMID: 28100182 Free PMC article.
αβ T-cell receptors from multiple sclerosis brain lesions show MAIT cell-related features.
Held K, Bhonsle-Deeng L, Siewert K, Sato W, Beltrán E, Schmidt S, Rühl G, Ng JK, Engerer P, Moser M, Klinkert WE, Babbe H, Misgeld T, Wekerle H, Laplaud DA, Hohlfeld R, Dornmair K. Held K, et al. Among authors: schmidt s. Neurol Neuroimmunol Neuroinflamm. 2015 May 7;2(4):e107. doi: 10.1212/NXI.0000000000000107. eCollection 2015 Aug. Neurol Neuroimmunol Neuroinflamm. 2015. PMID: 25977934 Free PMC article.
Real-world persistence and benefit-risk profile of fingolimod over 36 months in Germany.
Ziemssen T, Lang M, Tackenberg B, Schmidt S, Albrecht H, Klotz L, Haas J, Lassek C, Couto CA, Findlay JA, Cornelissen C; PANGAEA study group. Ziemssen T, et al. Among authors: schmidt s. Neurol Neuroimmunol Neuroinflamm. 2019 Mar 7;6(3):e548. doi: 10.1212/NXI.0000000000000548. eCollection 2019 May. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 30882022 Free PMC article.
4,378 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page